SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
- PMID: 32946791
- PMCID: PMC7492139
- DOI: 10.1016/j.cca.2020.09.018
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
Abstract
Aim: This study aims to verify whether standardized saliva collection is suitable for SARS-CoV-2 molecular detection and IgA measurement.
Methods: 43 COVID-19 inpatients and 326 screening subjects underwent naso-pharyngeal (NP)-swab and saliva collection (Salivette). Inpatients also underwent repeated blood collections to evaluate inflammation and organs involvement. In all patients and subjects, SARS-CoV-2 (gene E) rRT-PCR was undertaken in saliva and NP-swabs. Salivary IgA and serum IgA, IgG, IgM were measured on inpatients' samples.
Results: NP-swabs and saliva were both SARS-CoV-2 positive in 7 (16%) or both negative in 35 (82%) out of 43 patients successfully included in the study. NP-swabs and saliva results did not perfectly match in one patient (saliva positive, NP-swab negative). Positive molecular results were significantly associated with disease duration (p = 0.0049). 326/326 screening subjects were SARS-CoV-2 negative on both NP-swabs and saliva. Among the 27 saliva samples tested for IgA, 18 were IgA positive. Salivary IgA positivity was associated with pneumonia (p = 0.002) and CRP values (p = 0.0183), not with other clinical and molecular data, or with serum immunoglubulins.
Conclusions: A standardized saliva collection can be adopted to detect SARS-CoV-2 infection in alternative to NP-swabs. Preliminary data on salivary IgA support the use of saliva also for patient monitoring.
Keywords: Naso-pharyngeal swab; SARS-CoV-2; Saliva; Salivary IgA.
Copyright © 2020 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.J Infect Chemother. 2021 Jan;27(1):126-129. doi: 10.1016/j.jiac.2020.09.027. Epub 2020 Sep 30. J Infect Chemother. 2021. PMID: 33060046 Free PMC article.
-
Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study.J Korean Med Sci. 2020 Aug 10;35(31):e287. doi: 10.3346/jkms.2020.35.e287. J Korean Med Sci. 2020. PMID: 32776725 Free PMC article.
-
Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.J Virol Methods. 2020 Dec;286:113974. doi: 10.1016/j.jviromet.2020.113974. Epub 2020 Sep 16. J Virol Methods. 2020. PMID: 32949663 Free PMC article.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
-
Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2021 Feb 21;11(2):363. doi: 10.3390/diagnostics11020363. Diagnostics (Basel). 2021. PMID: 33670020 Free PMC article. Review.
Cited by
-
Saliva as a propitious diagnostic biofluid, biomarker, and bodies first line of defense against COVID-19: A review.J Family Med Prim Care. 2022 Jun;11(6):2292-2301. doi: 10.4103/jfmpc.jfmpc_1567_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119338 Free PMC article. Review.
-
Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination.J Med Virol. 2021 Sep;93(9):5257-5259. doi: 10.1002/jmv.27096. Epub 2021 May 28. J Med Virol. 2021. PMID: 34009653 Free PMC article. No abstract available.
-
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3. Microbiol Spectr. 2021. PMID: 34730436 Free PMC article.
-
Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases.Metabolites. 2023 Jul 27;13(8):889. doi: 10.3390/metabo13080889. Metabolites. 2023. PMID: 37623833 Free PMC article. Review.
-
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers.medRxiv [Preprint]. 2021 Feb 1:2021.01.28.21250717. doi: 10.1101/2021.01.28.21250717. medRxiv. 2021. Update in: J Clin Virol. 2021 Dec;145:104997. doi: 10.1016/j.jcv.2021.104997. PMID: 33532806 Free PMC article. Updated. Preprint.
References
-
- Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK– ninth update, 2020, 1–50.
-
- C.B.E.M. Reusken, E.K. Broberg, B. Haagmans, A. Meijer, V.M. Corman, A. Papa, et al., Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020, Euro Surveill. 25 (6) (2020). http://doi.org/10.2807/1560-7917.ES.2020.25.6.2000082. - PMC - PubMed
-
- World Health Organization (WHO) Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://apps.who.int/iris/handle/10665/330676, 2020 (accessed 15 June 2020).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous